AI Medical Technology receives CE mark in Europe

Stratipath Breast has received CE marking under the In Vitro Diagnostic Regulation (IVDR, EU 2017/746), the EU's most stringent regulatory framework for in vitro diagnostic medical devices.

Qlucore has received approval for a third payment of approximately EUR 0.5 million under its previously awarded EU grant. The total grant amounts to EUR 2.5 million and is distributed across four installments.

The Directed Share Issue was oversubscribed and included both new and existing investors, including Cicero Fonder, Storebrand Sverige Plus and Storebrand Sverige Småbolag Plus as well as Hallberg Management AB, Carl Bennet AB, LINC AB, and Nordea Småbolagsfond Norden.

Alvotech has announced the pricing of its previously announced underwritten public offering of 22,666,667 of its ordinary shares at an offering price of USD 3.75 per share.

Abera Bioscience has announces that CEPI (Coalition for Epidemic Preparedness Innovations) has decided to extend the ongoing project supporting the development of Abera’s BERA vaccine platform and the company’s innovative influenza vaccine candidate. 

The company has secured two major hospital contracts in Sweden and France, with a combined value of approximately SEK 16 million.

The Swedish spatial biology startup Haga Bioscience has closed a USD 2.3 million oversubscribed seed financing round bringing total funding, including pre-seed financing, to approximately USD 3 million.